CHRISTINA SLOTTER: Open Payments
NPI 1396339222 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 68 payments from 15 companies in 2025. Trend: 2023 $1,735 · 2024 $2,677 · 2025 $1,225
Food & beverage: $1,205Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $256 |
| Novo Nordisk Inc | 11 | $249 |
| PFIZER INC. | 12 | $217 |
| ABBVIE INC. | 12 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $81 |
| UCB, Inc. | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| Exact Sciences Corporation | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: Ozempic, ELIQUIS, FARXIGA, AIRSUPRA, CAPLYTA, UBRELVY, NURTEC ODT, VRAYLAR.
Industry payments across FL — which companies pay providers there.
